THUNDEROBOT
872190
Ji Yao Holding Group
300108
Hangzhou Huasu Technology
301157
Flaircomm Microelectronics, Inc.
301600
Jiusheng Electric
301082
CN Stock MarketDetailed Quotes
688073 Bide Pharmatech
- 47.20
- -0.65-1.36%
Market Closed Jan 7 15:00 CST
4.29BMarket Cap53.58P/E (TTM)
48.90High45.87Low12.27KlotVolume47.47Open47.85Pre Close57.78MTurnover2.84%Turnover Ratio39.14P/E (Static)90.88MShares53.2852wk High2.15P/B2.04BFloat Cap28.5052wk Low57.42Limit Up43.23MShs Float112.07Historical High38.28Limit Down6.33%Amplitude28.50Historical Low0.90Dividend TTM47.10Avg Price6.83KlotAsk1.91%Div YieldTTM100Lot Size4.49KlotBid
Bide Pharmatech News
Haitong Securities Co., Ltd. inspection opinions on the departure of core technicians of Shanghai Bide Pharmaceutical Technology Co., Ltd. and the addition of certified core technicians
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Supervisors
2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Announcement of Resolutions of the 13th Meeting of the 2nd Board of Directors
Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on the 2024 Restricted Stock Incentive Plan (Draft) of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Notice on Public Solicitation of Independent Directors\' Right to Delegate Voting
Bide Pharmaceutical: Announcement on changing the signed certified public accountant
Notice on changing the signed certified public accountant
Bide Pharmaceutical: Announcement on holding the results briefing for the third quarter of 2024
Announcement on holding the results briefing for the third quarter of 2024
Notice on the use of some temporarily idle funds raised for cash management
Announcement on renewing the Company\'s 2024 Audit Institution
Inspection opinions of Haitong Securities Co., Ltd. on Shanghai Bide Pharmaceutical Technology Co., Ltd. changing part of the fund-raising project and extending the implementation period
Inspection opinion of Haitong Securities Co., Ltd. on the development of foreign exchange hedging business by Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the Eighth Meeting of the Second Board of Supervisors
Resolutions of the First Special Meeting of Independent Directors of the Second Board of Directors
Inspection opinion of Haitong Securities Co., Ltd. on Shanghai Bide Pharmaceutical Technology Co., Ltd.\'s use of some overraised funds to repay bank loans and permanently supplement working capital
Notice on Using Part of the Overraised Funds to Repay Bank Loans and Permanently Replenish Liquidity
Opinions of Haitong Securities Co., Ltd. on the verification of the use of some temporarily idle funds raised by Shanghai Bide Pharmaceutical Technology Co., Ltd. for cash management
Bide Pharmaceutical: Verification Opinions on Haitong Securities Co., Ltd.\'s initial public offering of some restricted shares and circulation of Shanghai Bide Pharmaceutical Technology Co., Ltd.